Urology and surgical company Imagyn Medical Technologies of Newport Beach, CA, filed for Chapter 11 bankruptcy protection last week in an effort to preempt a group of creditors that has been trying to force the company into involuntary bankruptcy.
Urology and surgical company Imagyn Medical Technologies of Newport Beach, CA, filed for Chapter 11 bankruptcy protection last week in an effort to preempt a group of creditors that has been trying to force the company into involuntary bankruptcy. Imagyn executives said they plan to develop a reorganization plan for the company and solicit new financing to get the firm back on its feet. While Imagyn doesnt participate directly in the radiology segment, the company does have OEM relationships with several medical imaging companies, including International Isotopes and Fischer Imaging.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
MRI-Based AI Model Shows Promise in Predicting Lymph Node Metastasis with Breast Cancer
April 15th 2024For the prediction of axillary lymph node metastasis in patients with breast cancer, an MRI-based, 4D convolutional neural network model demonstrated an AUC of 87 percent and sensitivity of 89 percent, according to new research.